Haddadi A - Search Results

1

STAT3 silencing in dendritic cells by siRNA polyplexes encapsulated in PLGA nanoparticles for the modulation of anticancer immune response.

Alshamsan A, Haddadi A, Hamdy S, Samuel J, El-Kadi AO, Uludağ H, Lavasanifar A. Alshamsan A, et al. Among authors: haddadi a. Mol Pharm. 2010 Oct 4;7(5):1643-54. doi: 10.1021/mp100067u. Epub 2010 Sep 14. Mol Pharm. 2010. PMID: 20804176

2

Pharmaceutical analysis of synthetic lipid A-based vaccine adjuvants in poly (D,L-lactic-co-glycolic acid) nanoparticle formulations.

Hamdy S, Haddadi A, Somayaji V, Ruan D, Samuel J. Hamdy S, et al. Among authors: haddadi a. J Pharm Biomed Anal. 2007 Aug 15;44(4):914-23. doi: 10.1016/j.jpba.2007.03.010. Epub 2007 Mar 19. J Pharm Biomed Anal. 2007. PMID: 17590559

3

Delivery of rapamycin by PLGA nanoparticles enhances its suppressive activity on dendritic cells.

Haddadi A, Elamanchili P, Lavasanifar A, Das S, Shapiro J, Samuel J. Haddadi A, et al. J Biomed Mater Res A. 2008 Mar 15;84(4):885-98. doi: 10.1002/jbm.a.31373. J Biomed Mater Res A. 2008. PMID: 17647224

4

Delivery of rapamycin-loaded nanoparticle down regulates ICAM-1 expression and maintains an immunosuppressive profile in human CD34+ progenitor-derived dendritic cells.

Das S, Haddadi A, Veniamin S, Samuel J. Das S, et al. Among authors: haddadi a. J Biomed Mater Res A. 2008 Jun 15;85(4):983-92. doi: 10.1002/jbm.a.31557. J Biomed Mater Res A. 2008. PMID: 17907241

5

Micelles of poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin.

Ma Z, Haddadi A, Molavi O, Lavasanifar A, Lai R, Samuel J. Ma Z, et al. Among authors: haddadi a. J Biomed Mater Res A. 2008 Aug;86(2):300-10. doi: 10.1002/jbm.a.31584. J Biomed Mater Res A. 2008. PMID: 17957721

6

Resveratrol analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) mediates anti-tumor effects via mechanism different from that of resveratrol.

Ma Z, Molavi O, Haddadi A, Lai R, Gossage RA, Lavasanifar A. Ma Z, et al. Among authors: haddadi a. Cancer Chemother Pharmacol. 2008 Dec;63(1):27-35. doi: 10.1007/s00280-008-0704-z. Epub 2008 Feb 20. Cancer Chemother Pharmacol. 2008. PMID: 18286288

7

Topical delivery of urea encapsulated in biodegradable PLGA microparticles: O/W and W/O creams.

Haddadi A, Aboofazeli R, Erfan M, Farboud ES. Haddadi A, et al. J Microencapsul. 2008 Sep;25(6):379-86. doi: 10.1080/02652040802000714. J Microencapsul. 2008. PMID: 18465299

8

Co-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+ T cell-mediated anti-tumor immunity.

Hamdy S, Molavi O, Ma Z, Haddadi A, Alshamsan A, Gobti Z, Elhasi S, Samuel J, Lavasanifar A. Hamdy S, et al. Among authors: haddadi a. Vaccine. 2008 Sep 15;26(39):5046-57. doi: 10.1016/j.vaccine.2008.07.035. Epub 2008 Aug 3. Vaccine. 2008. PMID: 18680779

9

Formulation and delivery of siRNA by oleic acid and stearic acid modified polyethylenimine.

Alshamsan A, Haddadi A, Incani V, Samuel J, Lavasanifar A, Uludağ H. Alshamsan A, et al. Among authors: haddadi a. Mol Pharm. 2009 Jan-Feb;6(1):121-33. doi: 10.1021/mp8000815. Mol Pharm. 2009. PMID: 19053537

10

Active targeting of dendritic cells with mannan-decorated PLGA nanoparticles.

Ghotbi Z, Haddadi A, Hamdy S, Hung RW, Samuel J, Lavasanifar A. Ghotbi Z, et al. Among authors: haddadi a. J Drug Target. 2011 May;19(4):281-92. doi: 10.3109/1061186X.2010.499463. Epub 2010 Jun 30. J Drug Target. 2011. PMID: 20590403

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters